This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cremaschi, P. Articles by Cornalba, G.P. Search for Related Content PubMed PubMed Citation Articles by Cremaschi, P. Articles by Cornalba, G.P. Social Bookmarking                         What's this?

Therapeutic Embolization of Bronchial Artery: A Successful Treatment in 209 Cases of Relapse Hemoptysis

Division of Pneumology, I.R.C.C.S. S. Matteo, Pavia

C. Nascimbene

Division of Pneumology, I.R.C.C.S. S. Matteo, Pavia

P. Vitulo

Division of Pneumology, I.R.C.C.S. S. Matteo, Pavia

C. Catanese

Division of Pneumology, I.R.C.C.S. S. Matteo, Pavia

L. Rota

Institute of Radiology, University of Pavia

G.C. Barazzoni

Institute of Radiology, University of Pavia

G.P. Cornalba

Division of Radiology, L. Sacco Hospital, Milan, Italy

Still today bronchial artery embolization (BAE) is an important procedure in the management of hemoptysis, as an alternative to, or in association with, surgical or medical therapy. From 1974 to 1990, BAE was performed in 209 patients who suffered from hemoptysis with different etiopathogeneses and se verity. Bronchiectasias were the most frequent indication (46%) followed by tuberculosis (31%), cystic fibrosis (16%), lung cancer (4%), and aspergillosis (3%). BAEs were performed by means of polyvinyl alcohol particles and ab sorbable gelatin sponge. In a few cases complete occlusion of the main truncus of particularly large bronchial arteries was obtained by use of Gianturco steel coin (5 mm o) technique. In the last seven years, together with the traditional angiographic techniques, selective digital angiography (SDA) was performed, above all in preliminary control phases, to evaluate occlusion during emboliza tion. SDA reduced catheterization time and the mean quantity of contrast ad ministered, decreasing side effects; 98% of hemoptysis was controlled in the first twenty-four hours, the other 2% in the following forty eight hours; 16% relapses occurred within the first year; 27 patients needed reembolization (15 patients twice, 11 patients three times, 1 patient five times). No complications were seen. If diagnosis, therapeutic indications, operative technique, and equip ment selection are adequate, BAE has a high reliability in patients affected by relapsing hemoptysis, which is difficult to resolve.

Angiology, Vol. 44, No. 4, 295-299 (1993)
DOI: 10.1177/000331979304400405


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?